Dimed S.A. Distribuidora de Medicamentos (BVMF: PNVL3)

BVMF: PNVL3 Income Statement

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	4,818	4,461	3,990	3,225	2,819	2,725
Revenue Growth (YoY)	11.41%	11.79%	23.72%	14.41%	3.47%	12.02%
Cost of Revenue	3,288	3,079	2,745	2,231	1,988	1,908
Gross Profit	1,530	1,382	1,245	994.64	831.01	816.65
Selling, General & Admin	1,340	1,210	1,099	907.41	726.33	687.29
Other Operating Expenses	10.01	9.53	8	-15.56	11.29	10.5
Operating Expenses	1,350	1,220	1,107	891.85	737.62	697.79
Operating Income	179.6	161.89	137.84	102.78	93.39	118.86
Interest Expense	-103.09	-102.57	-70.03	-37.12	-35.31	-34.98
Interest & Investment Income	33.42	34.39	18.18	16.63	6.05	2.91
Other Non Operating Income (Expenses)	-9.26	-6.81	-7.01	2.2	-9.6	-6.78
EBT Excluding Unusual Items	100.67	86.9	78.99	84.49	54.54	80.02
Gain (Loss) on Sale of Assets	-4.04	-2.26	-2.07	-2.74	-1.85	-
Other Unusual Items	7.1	6.95	1.51	1.49	0.62	0.82
Pretax Income	103.73	91.58	78.43	83.24	53.3	80.84
Income Tax Expense	0.18	-1.32	-7.92	3.81	-2.85	4.09
Net Income	103.55	92.91	86.35	79.43	56.15	76.76
Net Income to Common	103.55	92.91	86.35	79.43	56.15	76.76
Net Income Growth	17.64%	7.60%	8.71%	41.45%	-26.84%	2.36%
Shares Outstanding (Basic)	149	149	149	150	151	135
Shares Outstanding (Diluted)	150	149	149	150	152	135
Shares Change (YoY)	0.73%	0.09%	-0.68%	-1.27%	11.84%	-0.55%
EPS (Basic)	0.69	0.62	0.58	0.53	0.37	0.57
EPS (Diluted)	0.69	0.62	0.58	0.53	0.37	0.57
EPS Growth	16.92%	6.90%	9.43%	43.02%	-34.59%	2.93%
Free Cash Flow	157.55	182.2	56.18	21.13	67.1	89.27
Free Cash Flow Per Share	1.05	1.23	0.38	0.14	0.44	0.66
Dividend Per Share	0.118	0.252	-	0.175	0.136	0.168
Dividend Growth	47.69%	-	-	28.37%	-19.11%	15.29%
Gross Margin	31.75%	30.97%	31.20%	30.84%	29.48%	29.97%
Operating Margin	3.73%	3.63%	3.45%	3.19%	3.31%	4.36%
Profit Margin	2.15%	2.08%	2.16%	2.46%	1.99%	2.82%
Free Cash Flow Margin	3.27%	4.08%	1.41%	0.66%	2.38%	3.28%
EBITDA	123.65	212.49	322.41	260.56	211.17	214.2
EBITDA Margin	2.57%	4.76%	8.08%	8.08%	7.49%	7.86%
D&A For EBITDA	-55.96	50.61	184.57	157.77	117.78	95.34
EBIT	179.6	161.89	137.84	102.78	93.39	118.86
EBIT Margin	3.73%	3.63%	3.45%	3.19%	3.31%	4.36%
Effective Tax Rate	0.17%	-	-	4.58%	-	5.05%
Revenue as Reported	4,818	4,461	3,990	3,225	-	-
Advertising Expenses	-	29.34	26.21	19.88	17.54	19.32

Source: S&P Capital IQ. Standard template. Financial Sources.